menthol has been researched along with Migraine Disorders in 5 studies
Menthol: A monoterpene cyclohexanol produced from mint oils.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mean migraine duration was 18." | 3.11 | A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study. ( Arkuszewski, M; Ecochard, L; Kim, BK; Li, Z; Lian, Y; Su, W; Wan, Q; Wang, H; Wang, SJ; Wen, S; Yin, F; Yu, S; Yu, T; Zhou, J, 2022) |
| "The menthol solution was also more efficacious in the alleviation of nausea and/or vomiting and phonophobia and/or photophobia (p = 0." | 2.75 | Cutaneous application of menthol 10% solution as an abortive treatment of migraine without aura: a randomised, double-blind, placebo-controlled, crossed-over study. ( Borhani Haghighi, A; Khodaei, S; Miri, R; Mohammadi, F; Motazedian, S; Pourmokhtari, M; Rezaii, R; Salarian, L; Vossoughi, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, S | 3 |
| Kim, BK | 3 |
| Wang, H | 3 |
| Zhou, J | 3 |
| Wan, Q | 3 |
| Yu, T | 3 |
| Lian, Y | 3 |
| Arkuszewski, M | 3 |
| Ecochard, L | 3 |
| Wen, S | 3 |
| Yin, F | 3 |
| Li, Z | 3 |
| Su, W | 3 |
| Wang, SJ | 3 |
| Lopresti, AL | 1 |
| Smith, SJ | 1 |
| Drummond, PD | 1 |
| Borhani Haghighi, A | 2 |
| Motazedian, S | 2 |
| Rezaii, R | 2 |
| Mohammadi, F | 1 |
| Salarian, L | 1 |
| Pourmokhtari, M | 1 |
| Khodaei, S | 1 |
| Vossoughi, M | 1 |
| Miri, R | 1 |
| Hare, RB | 1 |
1 review available for menthol and Migraine Disorders
| Article | Year |
|---|---|
Herbal treatments for migraine: A systematic review of randomised-controlled studies.
Topics: Acupuncture Therapy; Chamomile; Chemoprevention; Citrus; Combined Modality Therapy; Coriandrum; Huma | 2020 |
2 trials available for menthol and Migraine Disorders
| Article | Year |
|---|---|
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
Cutaneous application of menthol 10% solution as an abortive treatment of migraine without aura: a randomised, double-blind, placebo-controlled, crossed-over study.
Topics: Administration, Cutaneous; Adult; Aged; Analgesics; Analysis of Variance; Cross-Over Studies; Double | 2010 |
2 other studies available for menthol and Migraine Disorders
| Article | Year |
|---|---|
Therapeutic potentials of menthol in migraine headache: possible mechanisms of action.
Topics: Adjuvants, Pharmaceutic; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Humans; Menthol; Migra | 2007 |
Letter: An octogenarian reports.
Topics: Analgesia; Coffee; Menthol; Migraine Disorders; Myocardial Infarction; Oxygen Inhalation Therapy; Vi | 1973 |